Home
Glaxosmithkline Pharmaceuticals Ltd Quarterly Result

Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
Net Profit - Last Quarter
Glaxosmithkline Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Glaxosmithkline Pharmaceuticals Ltd for the Dec '24 is ₹ 984.49 crore as compare to the Sep '24 revenue of ₹ 1050 crore.
- This represent the decline of -6.24%a1# The ebitda of Glaxosmithkline Pharmaceuticals Ltd for the Dec '24 is ₹ 326.99 crore as compare to the Sep '24 ebitda of ₹ 360.94 crore.
- This represent the decline of -9.41%a1# The net profit of Glaxosmithkline Pharmaceuticals Ltd for the Dec '24 is ₹ 229.88 crore as compare to the Sep '24 net profit of ₹ 252.5 crore.
- This represent the decline of -8.96%a1#.
Glaxosmithkline Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Glaxosmithkline Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 2508.8 |
20 Feb 2025 | 2569.45 |
19 Feb 2025 | 2510.2 |
18 Feb 2025 | 2529.7 |
17 Feb 2025 | 2332.25 |
14 Feb 2025 | 2017.75 |
13 Feb 2025 | 1995.65 |
12 Feb 2025 | 2031.5 |
11 Feb 2025 | 2056.25 |
10 Feb 2025 | 2141.55 |
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd News Hub
Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter
Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju
Read more
05 Aug 24
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju
Read more
03 Aug 24
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O
Read more
25 Oct 24
Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend
GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting
Read more
29 Oct 24
Document
Concalls